MedPage Today -- SYDNEY, Australia, Feb. 18 -- The risk of diabetic kidney disease declined by 20% in patients treated with the investigational fixed-dose antihypertensive combination an international trial indicated.
MedPage Today -- SYDNEY, Australia, Feb. 18 -- The risk of diabetic kidney disease declined by 20% in patients treated with the investigational fixed-dose antihypertensive combination an international trial indicated.